Semble Raises £30M Series C
Semble, a London-based healthcare technology company that provides a clinical platform for outpatient care coordination, has secured £30 million in Series C funding. The company, which supports over 10 million patients across its network, is using the new capital to scale its operations and further develop its AI-driven care orchestration layer across the UK and Europe.
The funding round was led by European growth investor Revaia. Additional participation included new investor Partech, alongside existing backers Mercia Ventures and Octopus Ventures.
Semble plans to use the funding to drive expansion into larger healthcare groups, advance its position as an AI orchestration layer for modern care delivery, and strengthen its market presence in France.
Founded by Mikael Landau and Christoph Lippuner to address the fragmentation in healthcare delivery, Semble provides a clinical platform that connects and orchestrates the patient journey for outpatient providers. The platform integrates with over 1,200 tools and is currently used by 16,000 professionals across 1,700 healthcare businesses.
Funding Details
Company Website: https://semble.io
Company: Semble
Raised: £30M
Round: Series C
Funding Date: June 3, 2026
Lead Investor: Revaia
Additional Investors: Partech, Mercia Ventures, Octopus Ventures
Company Website: semble.io
Software Category: Health Technology